US Patent Issued to CELDARA MEDICAL, THE TRUSTEES OF DARTMOUTH COLLEGE on Feb. 10 for "Chimeric antigen receptors that target molecules on disease-associated macrophages and methods related thererto, and treatment of fibrotic, inflammatory and autoimmune conditions" (New Hampshire, Maryland Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,734, issued on Feb. 10, was assigned to CELDARA MEDICAL LLC (Lebanon, N.H.) and THE TRUSTEES OF DARTMOUTH COLLEGE (Lebanon, NH, US, Hanover, N.H.).

"Chimeric antigen receptors that target molecules on disease-associated macrophages and methods related thererto, and treatment of fibrotic, inflammatory and autoimmune conditions" was invented by Michael Whitfield (Etna, N.H.), Patricia Pioli (Etna, N.H.), Charles Sentman (Grantham, N.H.), Jake Reder (Hanover, N.H.), Joana Murad (Grantham, N.H.) and Yolanda Nesbeth (Bethesda, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides chimeric antigen receptors (CARs), nucleic acid sequenc...